Douglas A. Melton Biography, Age, Height, Wife, Net Worth, Family

Age, Biography and Wiki

Douglas A. Melton was born on 26 September, 1953 in Chicago, IL. Discover Douglas A. Melton's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 70 years old?

Popular AsDouglas A. Melton
OccupationN/A
Age70 years old
Zodiac SignLibra
Born26 September, 1953
Birthday26 September
BirthplaceChicago, IL
NationalityAmerican

We recommend you to check the complete list of Famous People born on 26 September. He is a member of famous with the age 70 years old group.

Douglas A. Melton Height, Weight & Measurements

At 70 years old, Douglas A. Melton height not available right now. We will update Douglas A. Melton's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
HeightNot Available
WeightNot Available
Body MeasurementsNot Available
Eye ColorNot Available
Hair ColorNot Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
ParentsNot Available
WifeNot Available
SiblingNot Available
ChildrenSam Melton, Emma Melton

Douglas A. Melton Net Worth

His net worth has been growing significantly in 2022-2023. So, how much is Douglas A. Melton worth at the age of 70 years old? Douglas A. Melton’s income source is mostly from being a successful . He is from American. We have estimated Douglas A. Melton's net worth , money, salary, income, and assets.

Net Worth in 2023$1 Million - $5 Million
Salary in 2023Under Review
Net Worth in 2022Pending
Salary in 2022Under Review
HouseNot Available
CarsNot Available
Source of Income

Douglas A. Melton Social Network

Timeline

His current research interests include pancreatic developmental biology and the directed differentiation of human embryonic stem cells, particularly in pertinence to type 1 diabetes. In 2014, he reported a method using human pluripotent stem cells to generate virtually unlimited quantities of insulin-producing beta cells that respond appropriately to a glucose challenge. This is considered a significant step forward in regenerative medicine for the possible treatment of diabetes, including type I diabetes, which afflicts both his children.

Melton grew up in Blue Island, Illinois and completed a Bachelor of Science degree in Biology at the University of Illinois at Urbana–Champaign in 1975. He was awarded a Marshall Scholarship for study at the University of Cambridge where he received a Bachelor of Arts degree in the History and Philosophy of Science in 1977 and a PhD under the supervision of John Gurdon.

In August 2008, Melton's lab published successful in vivo reprogramming of adult mice exocrine pancreatic cells into insulin secreting cells which closely resembled endogenous islet beta cells of the pancreas in terms of their size, shape, ultrastructure, and essential marker genes. Unlike producing beta cells from conventional embryonic stem cells or the more recently developed induced pluripotent stem cell (iPSC) technique, Melton's method involved direct cell reprogramming of an adult cell type (exocrine cell) into other adult cell type (beta cell) without reversion to a pluripotent stem cell state.

In 2001 when President George W. Bush cut federal funding of embryonic stem cell research, Melton used private donations to create 17 published stem cell lines and distributed them without charge to researchers around the world.

Melton was elected a member of the National Academy of Sciences and the American Academy of Arts and Sciences in 1995. In 2007 and again 2009, Melton was listed among Time Magazine's 100 Most Influential People in The World. In 2016, Melton was awarded the Ogawa-Yamanaka Prize in Stem Cell Biology.

Melton's early work was in general developmental biology, identifying genes important for cell fate determination and body pattern. This led to the finding that the nervous system in vertebrates is formed as a default when early embryonic cells do not receive inductive signals to become mesoderm or endoderm. He also pioneered the technique of in vitro transcription with bacterial SP6 RNA polymerase. In the mid-1990s, work in his lab became centered on the development of the pancreas aiming to find new treatments for diabetes.

You Might Also Like